Fibroblast growth factor 1 (FGF1) and FGF2, the prototypic members of the FGF family of growth factors, have been implicated in a variety of physiological and pathological processes. Unlike most other FGFs, FGF1 and FGF2 are ubiquitously expressed and are not efficiently secreted. Gene knockouts in mice have previously demonstrated a role for FGF2 in brain development, blood pressure regulation, and wound healing. The relatively mild phenotypic defects associated with FGF2 deletion led to the hypothesis that the continued expression of other FGFs partially compensated for the absence of FGF2 in these mice. We now report our generation of mice lacking FGF1 and their use, in combination with our previously described FGF2 null mice, to produce mice lacking both FGF1 and FGF2. FGF1-FGF2 double-knockout mice are viable and fertile and do not display any gross phenotypic defects. In the double-knockout mice we observed defects that were similar in extent to those previously described for the FGF2 null mice. Differences in the organization of neurons of the frontal motor cortex and in the rates of wound healing were observed. We also observed in FGF2 ؊/؊ mice and in FGF1-FGF2 double-knockout mice novel impairments in hematopoiesis that were similar in severity. Essentially no abnormalities were found in mice lacking only FGF1. Our results suggest that the relatively mild defects in FGF2 knockout animals are not a consequence of compensation by FGF1 and suggest highly restricted roles for both factors under normal developmental and physiological conditions. Fibroblast growth factors (FGFs) comprise a widely expressed and multifunctional family of polypeptides. FGFs transduce signals that can regulate cell growth, migration, differentiation, or survival. The biological activity of FGFs is mediated through interactions with transmembrane tyrosine kinase receptors. Four different receptors for FGFs are known, although each is present in multiple isoforms owing to alternative splicing of the mRNA. For the most part, there is no one-to-one correspondence between FGF ligands and receptors. A given FGF may be capable of multiple receptor isoforms; conversely, any receptor variant may bind multiple FGFs (3,8,19).FGF signaling has been implicated in a variety of physiological and pathological processes, ranging from angiogenesis to tumor progression. To date, however, the most clearly demonstrated role of FGF signaling is in development. Studies using knockout mice have demonstrated essential functions for FGF receptor 1 (FGFR1) and FGFR2 in early development (1, 12, 40, 41) and roles for FGFR3 in skeletal morphogenesis (9, 11). Studies of mice lacking individual FGFs reveal a variety of phenotypes which range from early embryonic lethality to very mild defects (14,16,17,22,23,27,30,31,34,42). These findings most likely reflect the redundancy of the FGF family of ligands or their uniqueness of expression in specific tissues.A total of 22 different FGF molecules have been described so far, although four of them (FGF-homologous fa...